Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

1.

Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.

Guevara M, Ginès P, Bandi JC, Gilabert R, Sort P, Jiménez W, Garcia-Pagan JC, Bosch J, Arroyo V, Rodés J.

Hepatology. 1998 Aug;28(2):416-22.

PMID:
9696006
[PubMed - indexed for MEDLINE]
2.

Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study.

Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, Kramer HJ, Spengler U, Schild H, Sauerbruch T.

Gut. 2000 Aug;47(2):288-95.

PMID:
10896924
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.

Wong F, Pantea L, Sniderman K.

Hepatology. 2004 Jul;40(1):55-64.

PMID:
15239086
[PubMed - indexed for MEDLINE]
4.

Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.

Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.

Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5.

PMID:
14696397
[PubMed - indexed for MEDLINE]
5.

Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.

Angeli P, Volpin R, Piovan D, Bortoluzzi A, Craighero R, Bottaro S, Finucci GF, Casiglia E, Sticca A, De Toni R, Pavan L, Gatta A.

Hepatology. 1998 Oct;28(4):937-43.

PMID:
9755229
[PubMed - indexed for MEDLINE]
6.

Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2.

Alessandria C, Venon WD, Marzano A, Barletti C, Fadda M, Rizzetto M.

Eur J Gastroenterol Hepatol. 2002 Dec;14(12):1363-8.

PMID:
12468959
[PubMed - indexed for MEDLINE]
7.

TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?

Gülberg V, Gerbes AL.

Z Gastroenterol. 2002 Sep;40(9):823-6. Review.

PMID:
12215953
[PubMed - indexed for MEDLINE]
8.

Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites.

Martinet JP, Legault L, Cernacek P, Roy L, Dufresne MP, Spahr L, Fenyves D, Pomier-Layrargues G.

J Hepatol. 1996 Nov;25(5):700-6.

PMID:
8938548
[PubMed - indexed for MEDLINE]
9.

Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function.

Somberg KA, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM.

Hepatology. 1995 Mar;21(3):709-16.

PMID:
7875668
[PubMed - indexed for MEDLINE]
10.

Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis.

Stadlbauer V, Wright GA, Banaji M, Mukhopadhya A, Mookerjee RP, Moore K, Jalan R.

Gastroenterology. 2008 Jan;134(1):111-9. doi: 10.1053/j.gastro.2007.10.055. Erratum in: Gastroenterology. 2008 Mar;134(3):897. Stadlbauer, Vanessa P [corrected to Stadlbauer, Vanessa]; Mookerjee, Rajeshwar [corrected to Mookerjee, Rajeshwar P].

PMID:
18166350
[PubMed - indexed for MEDLINE]
11.

Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.

Deschênes M, Dufresne MP, Bui B, Fenyves D, Spahr L, Roy L, Lafortune M, Pomier-Layrargues G.

Am J Gastroenterol. 1999 May;94(5):1361-5.

PMID:
10235219
[PubMed - indexed for MEDLINE]
12.

The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.

Rabie RN, Cazzaniga M, Salerno F, Wong F.

Am J Gastroenterol. 2009 Oct;104(10):2458-66. doi: 10.1038/ajg.2009.321. Epub 2009 Jun 16. Erratum in: Am J Gastroenterol. 2009 Aug;104(8):2128.

PMID:
19532126
[PubMed - indexed for MEDLINE]
13.

Systemic and splanchnic endothelin-1 plasma levels in liver cirrhosis before and after transjugular intrahepatic portosystemic shunt (TIPS).

Nolte W, Ehrenreich H, Wiltfang J, Pahl K, Unterberg K, Kamrowski-Kruck H, Schindler CG, Figulla HR, Buchwald AB, Hartmann H, Ramadori G.

Liver. 2000 Feb;20(1):60-5.

PMID:
10726962
[PubMed - indexed for MEDLINE]
14.

Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt.

Spahr L, Fenyves D, N'Guyen VV, Roy L, Legault L, Dufresne MP, Pomier-Layrargues G.

Am J Gastroenterol. 1995 Jul;90(7):1169-71.

PMID:
7611221
[PubMed - indexed for MEDLINE]
15.

Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.

Baron A, Gulberg V, Sauter G, Waggershauser T, Reiser M, Gerbes AL.

Hepatogastroenterology. 1998 Nov-Dec;45(24):2315-21.

PMID:
9951915
[PubMed - indexed for MEDLINE]
16.

Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.

Lotterer E, Wengert A, Fleig WE.

Hepatology. 1999 Mar;29(3):632-9.

PMID:
10051460
[PubMed - indexed for MEDLINE]
17.

Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites.

Wong F, Sniderman K, Liu P, Allidina Y, Sherman M, Blendis L.

Ann Intern Med. 1995 Jun 1;122(11):816-22.

PMID:
7741365
[PubMed - indexed for MEDLINE]
18.

Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.

Saló J, Guevara M, Fernández-Esparrach G, Bataller R, Ginès A, Jimenez W, Ginès P, Rivera F, Arroyo V, Rodés J.

Hepatology. 1997 Jun;25(6):1338-42.

PMID:
9185749
[PubMed - indexed for MEDLINE]
19.

Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.

Saló J, Ginès A, Quer JC, Fernández-Esparrach G, Guevara M, Ginès P, Bataller R, Planas R, Jiménez W, Arroyo V, Rodés J.

J Hepatol. 1996 Dec;25(6):916-23.

PMID:
9007721
[PubMed - indexed for MEDLINE]
20.

Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis.

Cassinello C, Moreno E, Gozalo A, Ortuño B, Cuenca B, Solís-Herruzo JA.

Dig Dis Sci. 2003 Jan;48(1):179-86.

PMID:
12645807
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk